Vivos Therapeutics Inc

Vivos Therapeutics Inc

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Vivos Therapeutics' stock with a target price of $6.20, indicating good growth potential.

Average

Financial Health

Vivos Therapeutics is generating moderate revenue and cash flow, with a reasonable profit margin.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring VVOS

Immersive Rehab & VR Therapy

Immersive Rehab & VR Therapy

Virtual and augmented reality are transforming healthcare with innovative digital treatments for physical and psychological healing. These carefully selected companies are at the forefront of creating immersive technologies that offer effective alternatives to traditional therapies, poised to benefit from growing clinical acceptance.

Published: June 17, 2025

Explore Basket
Rest & Recharge

Rest & Recharge

Tap into the booming wellness economy with companies revolutionizing how we sleep and relax. These carefully selected stocks represent innovative leaders in sleep technology, relaxation services, and wellness solutions that are responding to our growing desire for better rest and recovery.

Published: June 17, 2025

Explore Basket
Rest & Recovery

Rest & Recovery

This carefully curated collection features companies at the forefront of sleep science and recovery technology. These stocks represent a growing market where innovation meets wellness, selected by professional analysts tracking the expanding health optimization trend.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Sleep therapy growth

Rising awareness of sleep apnoea and interest in non‑CPAP options could create market opportunity, though clinical adoption and reimbursement will determine impact.

⚑

Small‑cap volatility

With a market cap around $20M, shares can be illiquid and volatile; this profile suits investors ready to accept higher risk and potential price swings.

🌍

Regulation and adoption

Regulatory approvals, clinical evidence and provider uptake are key growth leversβ€”outcomes here can materially influence future performance.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions